TickerFacts.

LENSAR, Inc. (LNSR): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$14.83M
Year ended 2025-12-31
-$7.29M
Trailing 12 months to 2026-06-30
2019-12-31: -$12.59M2020-12-31: -$13.79M2021-12-31: -$8.97M2022-12-31: -$14.86M2023-12-31: -$9.66M2024-12-31: -$2.27M2025-12-31: -$14.83M-$14.83M
2019-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$14.83Mn/m2026-03-31, From 2025-01-01
2024-12-31-$2.27Mn/m2026-03-31, From 2024-01-01
2023-12-31-$9.66Mn/m2025-02-27, From 2023-01-01
2022-12-31-$14.86Mn/m2024-03-04, From 2022-01-01
2021-12-31-$8.97Mn/m2023-03-16, From 2021-01-01
2020-12-31-$13.79Mn/m2022-03-03, From 2020-01-01
2019-12-31-$12.59Mn/a2021-03-12, From 2019-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
LENSAR, Inc. (LNSR)2025-12-31-$14.83Mn/m
CVRx, Inc. (CVRX)2025-12-31-$40.17Mn/m
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$569.9K-96.1%
Apyx Medical Corp (APYX)2025-12-31-$8.00Mn/m
Carlsmed, Inc. (CARL)2025-12-31-$28.98Mn/m
AVITA Medical, Inc. (RCEL)2025-12-31-$31.20Mn/m
Shoulder Innovations, Inc. (SI)2025-12-31-$28.61Mn/m
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$18.01Mn/m
Sight Sciences, Inc. (SGHT)2025-12-31-$29.69Mn/m

Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗